Formulary Search Results for: DASATINIB
8.1.5 Other antineoplastic drugs - View Category
Total Formulary
DASATINIB
Restrictions:
Restricted to specialist use in accordance with regional protocol for the following:
- Treatment of adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase is restricted to specialist use only in accordance with regional protocol - click here.
- Treatment of adult patients with chronic, accelerated or blast phase chronic myelogenous leukaemia (CML) with resistance or intolerance to prior therapy including imatinib mesilate is restricted to specialist use only in accordance with regional protocol - click here.
Prescribing Notes:
The following indications are not recommended by the SMC and are non-Formulary:
- ALL: Treatment of paediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukaemia in combination with chemotherapy (non-submission to SMC)